Rating History for Oyster Point Pharma (OYST) by Chardan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/8/2022 | Daniil Gatauli | Downgrade | Neutral (Buy) |
13.00 (N/A) |
8.35 (11.17) |
33.77% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/8/2022 | Daniil Gatauli | Downgrade | Neutral (Buy) |
13.00 (N/A) |
8.35 (11.17) |
33.77% | Details |
![]() |
|||||||